ATE498396T1 - Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes - Google Patents

Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes

Info

Publication number
ATE498396T1
ATE498396T1 AT08013091T AT08013091T ATE498396T1 AT E498396 T1 ATE498396 T1 AT E498396T1 AT 08013091 T AT08013091 T AT 08013091T AT 08013091 T AT08013091 T AT 08013091T AT E498396 T1 ATE498396 T1 AT E498396T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical formulation
digestive tract
upper digestive
antiinflammatory
Prior art date
Application number
AT08013091T
Other languages
German (de)
English (en)
Inventor
Markus Proels
Rudolf Wilhelm
Original Assignee
Falk Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39951664&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE498396(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Falk Pharma Gmbh filed Critical Falk Pharma Gmbh
Application granted granted Critical
Publication of ATE498396T1 publication Critical patent/ATE498396T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
AT08013091T 2008-07-21 2008-07-21 Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes ATE498396T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08013091A EP2151235B1 (de) 2008-07-21 2008-07-21 Pharmazeutische Formulierung zur Behandlung des oberen Verdauungstraktes

Publications (1)

Publication Number Publication Date
ATE498396T1 true ATE498396T1 (de) 2011-03-15

Family

ID=39951664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08013091T ATE498396T1 (de) 2008-07-21 2008-07-21 Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes

Country Status (23)

Country Link
US (2) US8580300B2 (enExample)
EP (2) EP2151235B1 (enExample)
JP (2) JP5616889B2 (enExample)
CN (1) CN102159196B (enExample)
AT (1) ATE498396T1 (enExample)
AU (1) AU2009273361B2 (enExample)
CA (1) CA2731312C (enExample)
CY (2) CY1111878T1 (enExample)
DE (1) DE502008002621D1 (enExample)
DK (2) DK2151235T3 (enExample)
EA (1) EA018465B1 (enExample)
ES (2) ES2358158T3 (enExample)
HR (2) HRP20130171T1 (enExample)
IL (1) IL210779A (enExample)
ME (2) ME01256B (enExample)
NZ (1) NZ590593A (enExample)
PL (2) PL2151235T3 (enExample)
PT (2) PT2151235E (enExample)
RS (2) RS51649B (enExample)
SI (2) SI2151235T1 (enExample)
UA (1) UA100759C2 (enExample)
WO (1) WO2010009961A1 (enExample)
ZA (1) ZA201100283B (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2000076478A1 (en) 1999-06-14 2000-12-21 Cosmo S.P.A. Controlled release and taste masking oral pharmaceutical compositions
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
PT2151235E (pt) * 2008-07-21 2011-03-21 Falk Pharma Gmbh Formulação farmacêutica para o tratamento do trato digestivo superior
CA2765033C (en) 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders
CN106421797A (zh) 2009-10-01 2017-02-22 艾戴尔医药公司 口服给予的皮质类固醇组合物
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
WO2015034678A2 (en) 2013-09-06 2015-03-12 Aptalis Pharmatech, Inc. Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
PL2886108T5 (pl) 2013-12-23 2023-02-27 Dr. Falk Pharma Gmbh Zoptymalizowana formulacja farmaceutyczna do leczenia zmian zapalnych przełyku
TWI777515B (zh) 2016-08-18 2022-09-11 美商愛戴爾製藥股份有限公司 治療嗜伊紅性食道炎之方法
WO2020084530A1 (en) 2018-10-24 2020-04-30 Ferring B.V. Mucoadhesive pharmaceutical compositions of corticosteroids

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4332394A1 (de) 1993-09-23 1995-03-30 Falk Pharma Gmbh Budesonid-Pellets mit kontrolliertem Freigabeprofil und Verfahren zu ihrer Herstellung
US5639475A (en) * 1995-02-03 1997-06-17 Eurand America, Incorporated Effervescent microcapsules
US5607697A (en) * 1995-06-07 1997-03-04 Cima Labs, Incorporated Taste masking microparticles for oral dosage forms
US5807578A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
US5807577A (en) * 1995-11-22 1998-09-15 Lab Pharmaceutical Research International Inc. Fast-melt tablet and method of making same
GB9611364D0 (en) * 1996-05-31 1996-08-07 Smithkline Beecham Plc Composition
US6350470B1 (en) * 1998-04-29 2002-02-26 Cima Labs Inc. Effervescent drug delivery system for oral administration
JP3818789B2 (ja) * 1999-02-18 2006-09-06 三菱化学フーズ株式会社 易崩壊性錠剤
WO2003006629A1 (en) 2001-07-11 2003-01-23 Toshirou Sekine Culturing method and device for photosynthetic microbes
CA2461042A1 (en) * 2001-09-25 2003-04-03 Ashish Madan Process for the preparation of fast dissolving dosage form
WO2003043518A2 (en) * 2001-11-20 2003-05-30 Dmi Biosciences, Inc. Methods and products for oral care
JP2005526095A (ja) * 2002-03-20 2005-09-02 エラン ファーマ インターナショナル，リミティド 脆砕性の低い急速溶解投与剤型
SE0401031D0 (sv) * 2004-04-22 2004-04-22 Duocort Ab A new glucocorticoid replacement therapy
US20060013873A1 (en) * 2004-07-16 2006-01-19 Chih-Chiang Yang Bioadhesive dosage form of steroids
US20070071817A1 (en) * 2005-09-26 2007-03-29 Phyzz, Inc. Effervescent oral care compositions and method of use
US20070191323A1 (en) * 2006-02-15 2007-08-16 Verus Pharmaceuticals, Inc. Stable corticosteroid mixtures
SI2170348T1 (sl) * 2007-06-22 2016-12-30 Dompe Farmaceutici S.P.A. Šumeče tablete za inhalacijsko uporabo
WO2009043844A2 (en) * 2007-10-01 2009-04-09 Laboratorios Lesvi, S.L. Orodispersible tablets
PT2151235E (pt) * 2008-07-21 2011-03-21 Falk Pharma Gmbh Formulação farmacêutica para o tratamento do trato digestivo superior
CA2765033C (en) * 2009-06-12 2020-07-14 Meritage Pharma, Inc. Methods for treating gastrointestinal disorders

Also Published As

Publication number Publication date
HRP20130171T1 (hr) 2013-03-31
DE502008002621D1 (de) 2011-03-31
US8580300B2 (en) 2013-11-12
SI2151235T1 (sl) 2011-04-29
CN102159196B (zh) 2013-05-08
EP2151235B1 (de) 2011-02-16
PT2151235E (pt) 2011-03-21
JP2011528679A (ja) 2011-11-24
JP2014221827A (ja) 2014-11-27
US20110123460A1 (en) 2011-05-26
EA018465B1 (ru) 2013-08-30
HK1149907A1 (en) 2011-10-21
EP2306988B1 (de) 2013-01-09
ME01256B (me) 2013-06-20
CY1111878T1 (el) 2015-11-04
IL210779A0 (en) 2011-03-31
PT2306988E (pt) 2013-02-15
ES2358158T3 (es) 2011-05-06
NZ590593A (en) 2012-07-27
SI2306988T1 (sl) 2013-03-29
WO2010009961A1 (de) 2010-01-28
CA2731312C (en) 2016-05-10
ES2399321T3 (es) 2013-03-27
PL2151235T3 (pl) 2011-05-31
CY1113719T1 (el) 2016-06-22
HRP20110208T1 (hr) 2011-04-30
AU2009273361B2 (en) 2014-03-20
RS51649B (sr) 2011-10-31
JP6209495B2 (ja) 2017-10-04
PL2306988T3 (pl) 2013-04-30
DK2306988T3 (da) 2013-03-18
CA2731312A1 (en) 2010-01-28
CN102159196A (zh) 2011-08-17
RS52662B (sr) 2013-06-28
AU2009273361A1 (en) 2010-01-28
JP5616889B2 (ja) 2014-10-29
IL210779A (en) 2015-07-30
EA201100229A1 (ru) 2011-08-30
ZA201100283B (en) 2011-10-26
UA100759C2 (uk) 2013-01-25
ME01494B (me) 2014-04-20
EP2151235A1 (de) 2010-02-10
DK2151235T3 (da) 2011-04-11
EP2306988A1 (de) 2011-04-13
US20140079646A1 (en) 2014-03-20

Similar Documents

Publication Publication Date Title
ATE498396T1 (de) Pharmazeutische formulierung zur behandlung des oberen verdauungstraktes
NZ591873A (en) Co-crystals of tramadol and nsaids
IL255752B (en) Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer
MX354210B (es) Formas farmaceuticas orales de liberacion controlada de farmacos escasamente solubles y los usos de estas.
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
ZA201201060B (en) Combination of an oxidant,a photosensitizer and a wound healing agent for oral disinfection and treatment or oral disease
EP2413930A4 (en) ORAL FORMULATION OF ENDOTHELIN AND ANGIOTENSIN II RECEPTOR AGONISTS BASED ON DIPHENYLSULFONAMIDE TO TREAT HIGH BLOOD PRESSURE AND DIABETIC NEPHROPATHY
MX347106B (es) Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
WO2007038459A3 (en) Carboxyamine compounds and their use in the treatment of hdac dependent diseases
IL197575A (en) A method for removing adult stem cells from the blood, using them to prepare drugs for the treatment of lesions, and a medical preparation containing these adult GES cells
CY1116831T1 (el) ΧΡΗΣΗ 24-norUDCA
WO2011072069A3 (en) Gastric retentive pharmaceutical compositions for extended release of polypeptides
UA96794C2 (ru) Глюкокортикоиды, способ их применения, способ лечения и фармацевтическая композиция на их основе
DE102009018133A8 (de) Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
DE502008002255D1 (de) Arzneimittel enthaltend Fraumenmantel zur Behandlung von Endometritis, Vaginitis
ITMI20051231A1 (it) Formulazioni farmaceutiche contenenti colostro e calcio folinato per il trattamento delle affezioni del cavo orale
MX2013007959A (es) Formas farmaceuticas orales de amida {2-[(1s)-1-(3-etoxi-4-metoxi- fenil]-2-metansulfonil-etil]-3-oxo-2,,3-dihidro-1h-isoindol -4-il}-del acido ciclopropancarboxilico.
TN2012000075A1 (en) Co-crystals of tramadol and coxibs
DE602006012310D1 (de) An titandioxidnanopartikeln absorbierte pharmazeutische wirkstoffe enthaltende pharmazeutische formulierungen
PL1837029T3 (pl) Kompozycja farmaceutyczna do zapobiegania i leczenia przeziębień
TWI365753B (en) Use of adamantyl methoxydiphenyl propenoic acid for the treatment of dermatological diseases
DE602005011029D1 (de) Therapeutisches mittel zur behandlung von plasmazellneoplasien
UA71564U (ru) Средство для лечения и профилактики урологических заболеваний для перорального применения
UA38368U (ru) Лечебно-профилактический фитосироп "иммуностимулин"